We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 18,358 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 2k | -1.28M | -0.0071 | -1.13 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/2/2018 12:04 | Someone has just picked up 400,000 of N4 Edit. Deal was time at 16.29 yesterday. | hughwilson | |
08/2/2018 11:58 | For information, 1,729,410 warrants equate to £146,999.85 flowing into N4`s coffers to speed up the various projects. There remain 13,454,833 warrants outstanding | hughwilson | |
08/2/2018 11:52 | RNS RNS Number : 3318E N4 Pharma PLC 08 February 2018 N4 Pharma Plc ("N4 Pharma" or the "Company") Exercise of Warrants and Total Voting Rights The Company announces that it has received exercise notices for the exercise of 1,729,410 warrants over ordinary shares of 0.4p each at an exercise price of 8.5 pence per warrant ("New Ordinary Shares"). Application has been made for admission of 1,729,410 New Ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading will commence on AIM at 8.00 a.m. on 9 February 2018. Following Admission, there will be a total of 87,279,423 ordinary shares in issue. Shareholders should use the figure of 87,279,423 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the FCA's Disclosure and Transparency Rules. | hughwilson | |
08/2/2018 10:57 | Flash, no idea what you are on about. | jimbobaroony | |
08/2/2018 10:15 | Parob, One of the problems of being an investor on a BB is that your interests are not always aligned with those of a trader. As an investor I invest in companies that I think will do well resulting in a higher share price A trader may post positives under one name and negatives under another. While the investor and traders interests may be aligned when a share rises, on a perceived resistant point for the share price the traders come out of the woodwork trying to force the share price back down making a profit on both sides. While there is nothing wrong with that form of trading, one of the disappointing sides for me posting on a BB is that one of the techniques used by traders is to identify who the main bullish posters are on a BB and then proceed to attack them personally in the hope of causing disharmony on the board in the hope that people will sell. I will leave it up to others to decide if that is happening here but it is something to look out for. | hughwilson | |
08/2/2018 10:01 | I can see it bouncing off 25p today .... | jakleeds | |
08/2/2018 10:01 | I meant to write he (not we!) sold a chunk at 21.5p.Now let's see if the 50K block buyer returns this pm. | parob | |
08/2/2018 09:49 | Talking of double posters.........jimb | flashheart | |
08/2/2018 09:48 | Hugh,We sold a chunk at 21.5p.I'll say no more. | parob | |
08/2/2018 09:47 | "This will involve mentioning potential risks and downsides." Exactly. By your own admission, N4P has no obvious Achilles heel and your mentioning of risks and downsides are posted without any supporting evidence whatsoever. I take that as meaning you are trying to create doubt and fear in the minds of investors for your own purpose. | hughwilson | |
08/2/2018 09:25 | Yes, exactly. I'm trying to generate a balanced discussion. This will involve mentioning potential risks and downsides. | jimbobaroony | |
08/2/2018 09:13 | jakleeds, "Not sure what jimbob’s motives are ...." Jim answers that question in one of his previous posts. "This board has plenty if posters highlighting the positives of N4P and it's great potential. However, I don't see much posted to counterbalance this perspective. This is because N4P genuinely does seem to have great future prospects and has no obvious Achilles heel for bashes to focus on. A few posters on here are doing their level best to ramp this for all it's worth. Therefore, In the interests of creating a balanced argument I'll take the opposing view" | hughwilson | |
08/2/2018 08:56 | Agreed, Jakleeds. Hugh, you give us investors' confidence with informative research on this company. Last weeks news will get the attention it deserves and further news will rerate, eventually, into profit for this amazing company, it's LTHs and ceo:))) | ch1rp | |
08/2/2018 08:55 | Jim, People look in to a BB for news and information about a share. It is exactly that that I provide. | hughwilson | |
08/2/2018 08:49 | Keep posting please Hugh. I for one (and probably everyone else bar one person ) find your posts extremely useful and informative . Not sure what jimbob’s motives are .... | jakleeds | |
08/2/2018 08:39 | Bored now. | jimbobaroony | |
08/2/2018 08:36 | Hugh, It is NTs job to represent his company. We can all read / listen to the presentations. It's not adding value by continually posting bits of them here. | jimbobaroony | |
08/2/2018 08:10 | Jim, "Hundreds of deals? If that is not a ramp, I would to know what is!" The reference to hundreds of deals came from the presentation where Nigel referred to there being hundreds of companies looking for a delivery system for their drugs. By your reckoning, Nigel is the biggest ramper of all. | hughwilson | |
08/2/2018 08:02 | bloody hell guys, Lots of posts... I think we all agree an 8 month old bio is not without risk, but the case for investing is all there to see , and see that concensus is 3-5 times cuurent share price (now) then i dont think there is much to disagree about. News can always change this opinion - OBVIOUSLY -but have to look at the stength in the board and recent actions show this little co intends to not be a little co for very long GLA onwards and Upwards | urigem | |
07/2/2018 23:36 | Jim, Answering questions and providing information is not ramping. You even go as far as accusing me of posting under different names, all of which is complete rubbish. "Parob, is it about time you stopped posting as hughwilson? It's getting a bit tiresome." "hughwilson aka Parob" "I see you also tag team post on the lse boards!" "Parob is also posting as hughwilson" "Hughwilson started posting on advfn 21st January 2018. All posts concerning N4P. Claims to have worked in the pharmaceutical world. This is EXACTLY the kind of poster I would be very wary of." It would seem that you have an issue with me as a poster. I never say anything that cannot be backed up. A ramper I am not nor would I care to be. This share does not need rampers as the news is positive enough. | hughwilson | |
07/2/2018 23:19 | Hugh, When read in context, all my posts I believe to be balanced. The post about spoiling your fun was a bit unnecessary I agree. Having said that I do believe you to be blatantly ramping N4p. | jimbobaroony | |
07/2/2018 23:19 | As you can see Myles has added 1,750,000 shares since the end of last year and has also exercised warrants. In my book that is a massive vote of confidence by an ex city analyst who puts his money where his mouth is. | hughwilson | |
07/2/2018 23:11 | Hugh, OK thanks, corrected my post | jimbobaroony |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions